Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers. 2021

Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
Department of Pharmacy, Peking University First Hospital, Beijing, China.

Remimazolam is a new ultra-short-acting benzodiazepine used to induce and maintain anesthesia and procedural sedation. Its compound structure is similar to midazolam's. Midazolam metabolism might be affected by vitamin D receptor (VDR), cytochrome P450 3A, and cytochrome P450 oxidoreductase genetic polymorphisms. This study investigated the effects of VDR, cytochrome P450 3A, and cytochrome P450 oxidoreductase genetic polymorphisms on the pharmacokinetics of remimazolam in healthy Chinese volunteers after a single intravenous injection of remimazolam besylate. Blood samples were collected from subjects (n = 62) at scheduled time intervals before and after injection. High-performance liquid chromatography-tandem mass spectrometry was used to quantify plasma remimazolam and RF7054 (its inactive carboxylic acid metabolite) concentrations. The relationship between plasma remimazolam concentration, pharmacokinetic parameters, and polymorphic alleles was assessed for each subject. The rs4516035 allele affected the elimination half-life of RF7054 (P = .043), while the rs1544410 allele affected the dose-normalized maximum observed plasma concentration (Cmax /D) of remimazolam (P = .025) in 46 volunteers. Results showed that VDR genetic polymorphisms might affect the pharmacokinetics of remimazolam in the Chinese population.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
January 2021, PloS one,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
April 2018, American journal of epidemiology,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
April 2013, European journal of clinical pharmacology,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
December 2023, Xenobiotica; the fate of foreign compounds in biological systems,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
May 2020, Molecular genetics & genomic medicine,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
October 2005, Methods and findings in experimental and clinical pharmacology,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
February 2016, Pharmacogenetics and genomics,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
December 2016, Human genetics,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
February 2024, Drug metabolism and disposition: the biological fate of chemicals,
Kun Hu, and Qian Xiang, and Zhe Wang, and Xiaoyan Sheng, and Li'e Li, and Yan Liang, and Xia Zhao, and Xia Ye, and Yimin Cui
January 2008, Pharmacogenetics and genomics,
Copied contents to your clipboard!